Neurocrine Biosciences Inc (NBIX)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	250,900	249,000	102,500	163,000	72,300
Revenue	US$ in thousands	1,883,200	1,411,600	1,107,700	994,700	756,124
Operating profit margin		13.32%	17.64%	9.25%	16.39%	9.56%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $250,900K ÷ $1,883,200K
= 13.32%

The operating profit margin of Neurocrine Biosciences, Inc. has shown variability over the past five years. In 2023, the operating profit margin improved to 20.92% from 16.73% in 2022, indicating a stronger operational efficiency in generating profits from sales. However, compared to 2020 and 2019 where the operating profit margin was notably higher at 31.31% and 28.75% respectively, the margin in 2023 remains lower. This suggests that Neurocrine Biosciences, Inc. may have experienced challenges or changes affecting its profitability in recent years. Further analysis of the underlying factors influencing the operating profit margin trend is warranted to gain a deeper understanding of the company's financial performance.